Oseltamivir Phosphate
Product Images NDC 67296-2078

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oseltamivir Phosphate (NDC 67296-2078). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (A1279325 8446 412f 83b1 46ed6c5666c0 01)

FDA Label Image

Principal Display Panel (Carton-30)

Principal Display Panel (Carton-30)
This is an output for a medication called Oseltamivir Phosphate capsules, USP. Each capsule contains 30 mg of Oseltamivir Phosphate. The recommended storage temperature is between 20° to 25°C. For usage dosage and important prescribing information, refer to the accompanying insert. The medication is distributed by Strides Pharma Inc. based in East Brunswick, NJ.*
FDA Label Image

Principal Display Panel (Carton-45mg)

Principal Display Panel (Carton-45mg)
This text provides information about Oseltamivir Phosphate Capsules, USP, which come in a package of 10 (1x10 unit-dose) capsules. Each capsule contains Oseltamivir Phosphate equivalent to 45 mg of Oseltamivir free base. The usage dosage, storage instructions, manufacturing details by Strides Pharma Science Limited, and distribution information by Strides Pharma Inc. are also included. For more prescribing details, it is advised to refer to the accompanying insert.*
FDA Label Image

Principal Display Panel (Carton-75mg)

Principal Display Panel (Carton-75mg)
This is a description of a medication called Oseltamivir Phosphate, which comes in capsules containing 75 mg of the active ingredient. The dosage recommendations and other prescribing information can be found in the accompanying insert. The medication should be stored at temperatures between 20 to 25 degrees Celsius, with excursions permitted to 15 to 30 degrees Celsius. The product is distributed by Strides Pharma Inc. and the code number for identification is provided. The text mentions limited details about the manufacturer and revision date.*
FDA Label Image

Principal Display Panel (30 mg foil)

FDA Label Image

Principal Display Panel (45 mg foil)

FDA Label Image

Principal Display Panel (75 mg foil)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.